Both in Pharmaceuticals
Acrivon Therapeutics vs Biomea Fusion
Over the past year ACRV returned +14.3% and BMEA returned −38.8%; their daily moves had a correlation of 0.13.
ACRV +14.3% BMEA −38.8%Growth of $1, one year, split-adjusted
| Metric | ACRV | BMEA |
|---|---|---|
| Price | $2.08 | $1.26 |
| Market cap | $89.1M | $91.3M |
| Today | +0.97% | −2.33% |
| 1 month | +1.0% | −27.2% |
| 6 months | +61.2% | −4.5% |
| Year to date | −13.7% | +1.6% |
| 1 year | +25.3% | −40.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $90.0M | $34.8M |
| Dividend yield | — | — |
| Volatility (60d) | 77.7% | 73.0% |
| Short % of float | 5.0% | 20.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).